Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature-Reference-Cited by-同舟云学术

Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature

Published:2017-11-16 Issue:2 Volume:36 Page:157-170
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Mari Andrea,Campi Riccardo,Tellini Riccardo,Gandaglia Giorgio,Albisinni Simone,Abufaraj Mohammad,Hatzichristodoulou Georgios,Montorsi Francesco,van Velthoven Roland,Carini Marco,Minervini Andrea,Shariat Shahrokh F.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-017-2115-4/fulltext.html

Reference60 articles.

1. Alfred Witjes J, Lebret T, Comperat EM et al (2016) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. https://doi.org/10.1016/j.eururo.2016.06.020

2. Chromecki TF, Cha EK, Fajkovic H et al (2013) Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int 111:249–255. https://doi.org/10.1111/j.1464-410X.2012.11322.x

3. Xylinas E, Cha EK, Sun M et al (2012) Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. Br J Cancer 107:1826–1832. https://doi.org/10.1038/bjc.2012.464

4. Zehnder P, Studer UE, Skinner EC et al (2013) Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int 112:E51–E58. https://doi.org/10.1111/bju.12215

5. Roupret M, Drouin SJ, Larre S et al (2011) Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study. Ann Surg Oncol 18:3833–3838. https://doi.org/10.1245/s10434-011-1824-y

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database;Heliyon;2024-09

2. The evolving treatment landscape of metastatic urothelial cancer;Nature Reviews Urology;2024-05-03

3. Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI radiomics;Insights into Imaging;2024-03-25

4. Current role of radiomics and radiogenomics in predicting oncological outcomes in bladder cancer;Current Urology;2024-01-11

5. Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study;International Journal of Radiation Oncology*Biology*Physics;2024-01